Advances in Fecal Microbiota Transplantation for Gut Dysbiosis-Related Diseases.

This article provides an overview of the advancements in the application of fecal microbiota transplantation (FMT) in treating diseases related to intestinal dysbiosis. FMT involves the transfer of healthy donor fecal microbiota into the patient's body, aiming to restore the balance of intestinal microbiota and thereby treat a variety of intestinal diseases such as recurrent Clostridioides difficile infection (rCDI), inflammatory bowel disease (IBD), constipation, short bowel syndrome (SBS), and irritable bowel syndrome (IBS). While FMT has shown high efficacy in the treatment of rCDI, further research is needed for its application in other chronic conditions.

Immunotherapy of osteosarcoma based on immune microenvironment modulation.

Osteosarcoma is a highly malignant tumor with unsatisfactory therapeutic outcomes achieved by chemotherapy, radiotherapy, and surgery. As an emerging oncological treatment, immunotherapy has shown potential in the clinical management of many tumors but has a poor response rate in osteosarcoma. The immunosuppressive microenvironment in osteosarcoma is the main reason for the ineffectiveness of immunotherapy, in which the low immune response rate of immune effector cells and the high activation of immunosuppressive cells contribute to this outcome.

Preparation of ZnFeO/AC composite and its adsorption behaviour for SO.

ZnFeO/AC composites were prepared by a one-pot hydro-thermal method using the activated carbon as a carrier. The structural, textural and surface properties of the adsorbent have been comprehensively characterized by scanning electron microscopy (SEM), X-ray diffraction (XRD), Raman spectra, physical adsorption instrument (BET) and TG-DSC analysis. The removal capacities of the composites were investigated via testing the adsorption capacity at the self-made desulfurization equipment.